Group One Trading’s NeoGenomics NEO Stock Holding History

Group One Trading’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,000	Closed	-$11.8K	–	8357
2025 Q4	$11.8K	Sell	1,000 -20,300	-95%	-$219K	﹤0.01%	6713
2025 Q3	$164K	Sell	21,300 -5,800	-21%	-$40.6K	﹤0.01%	4885
2025 Q2	$198K	Buy	27,100 +26,600	+5,320%	+$215K	﹤0.01%	4350
2025 Q1	$4.75K	Buy	+500	New	+$6.24K	﹤0.01%	6670
2024 Q3	–	Sell	-58,200	Closed	-$807K	–	7103
2024 Q2	$807K	Sell	58,200 -6,700	-10%	-$95K	﹤0.01%	2169
2024 Q1	$1.02M	Buy	64,900 +41,400	+176%	+$639K	﹤0.01%	2070
2023 Q4	$380K	Sell	23,500 -35,500	-60%	-$581K	﹤0.01%	3301
2023 Q3	$726K	Buy	59,000 +38,800	+192%	+$577K	﹤0.01%	2566
2023 Q2	$325K	Buy	20,200 +18,400	+1,022%	+$303K	﹤0.01%	3464
2023 Q1	$31.3K	Sell	1,800 -41,200	-96%	-$587K	﹤0.01%	5205
2022 Q4	$397K	Sell	43,000 -7,800	-15%	-$72.7K	﹤0.01%	3248
2022 Q3	$437K	Buy	50,800 +47,400	+1,394%	+$471K	﹤0.01%	3363
2022 Q2	$28K	Sell	3,400 -5,800	-63%	-$55.4K	﹤0.01%	6038
2022 Q1	$112K	Buy	9,200 +5,000	+119%	+$105K	﹤0.01%	5381
2021 Q4	$143K	Sell	4,200 -400	-9%	-$15.7K	﹤0.01%	5411
2021 Q3	$222K	Sell	4,600 -9,100	-66%	-$421K	﹤0.01%	5060
2021 Q2	$619K	Buy	13,700 +1,500	+12%	+$66.5K	﹤0.01%	3980
2021 Q1	$588K	Sell	12,200 -5,300	-30%	-$276K	﹤0.01%	3832
2020 Q4	$942K	Sell	17,500 -6,900	-28%	-$312K	﹤0.01%	2697
2020 Q3	$900K	Buy	24,400 +15,300	+168%	+$569K	﹤0.01%	2297
2020 Q2	$282K	Buy	9,100 +2,800	+44%	+$77.6K	﹤0.01%	3102
2020 Q1	$174K	Buy	6,300 +2,300	+58%	+$68.9K	﹤0.01%	2870
2019 Q4	$117K	Sell	4,000 -12,300	-75%	-$293K	﹤0.01%	3544
2019 Q3	$312K	Buy	16,300 +3,300	+25%	+$77.4K	﹤0.01%	2736
2019 Q2	$285K	Buy	13,000 +7,500	+136%	+$165K	﹤0.01%	2600
2019 Q1	$113K	Buy	5,500 +1,500	+38%	+$26.1K	﹤0.01%	3090
2018 Q4	$50K	Buy	+4,000	New	+$59.6K	﹤0.01%	3565
2018 Q3	–	Sell	-200	Closed	-$3K	–	5463
2018 Q2	$3K	Hold	200	–	–	﹤0.01%	4899
2018 Q1	$2K	Buy	+200	New	+$1.62K	﹤0.01%	4642
2017 Q3	–	Sell	-200	Closed	-$2K	–	5040
2017 Q2	$2K	Hold	200	–	–	﹤0.01%	4569
2017 Q1	$2K	Sell	200 -2,800	-93%	-$22.8K	﹤0.01%	4452
2016 Q4	$26K	Buy	3,000 +2,700	+900%	+$23.1K	﹤0.01%	3590
2016 Q3	$2K	Sell	300 -700	-70%	-$5.87K	﹤0.01%	4374
2016 Q2	$8K	Buy	1,000 +300	+43%	+$2.4K	﹤0.01%	4144
2016 Q1	$5K	Buy	700 +200	+40%	+$1.32K	﹤0.01%	4201
2015 Q4	$4K	Buy	+500	New	+$3.66K	﹤0.01%	4417
2015 Q2	–	Sell	-5,000	Closed	-$23K	–	5045
2015 Q1	$23K	Sell	5,000 -1,000	-17%	-$4.35K	﹤0.01%	3820
2014 Q4	$25K	Sell	6,000 -2,700	-31%	-$12.4K	﹤0.01%	3832
2014 Q3	$45K	Sell	8,700 -200	-2%	-$1.03K	﹤0.01%	3589
2014 Q2	$30K	Buy	8,900 +3,400	+62%	+$11.3K	﹤0.01%	3892
2014 Q1	$19K	Buy	5,500 +2,100	+62%	+$7.87K	﹤0.01%	4272
2013 Q4	$12K	Buy	+3,400	New	+$11.8K	﹤0.01%	4515

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Group One Trading's NEO Position: Q1 2026 in Review

Group One Trading sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 3,847 shares — an estimated $40.5K sold.

Group One Trading first reported a position in NEO in Q4 2013 and held it in 11 quarters. The position peaked at $437K in Q3 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Group One Trading reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 3,847 NeoGenomics shares in Q1 2026, an estimated $40.5K.
Group One Trading first reported a position in NeoGenomics in Q4 2013 and held it in 11 quarters.
Group One Trading's NeoGenomics position peaked at $437K in Q3 2022.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.